SC Filed 2024-07-08 Event — SEC 0001104659-24-078287 →

DUGGAN ROBERT W → PULSE BIOSCIENCES, INC. PLSE

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

46 transactions

14 buys · 15 sales · 17 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

18 filings by this filer

17 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 11.62

2,889,600 shares short · +1.2% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-05-11	DUGGAN ROBERT W	director, 10%+ owner	Buy	660,233	$19.69	$13.00M
2026-05-11	LAVIOLETTE PAUL A	director, officer	Buy	15,000	$19.69	$295K
2026-05-11	LAVIOLETTE PAUL A	director, officer	Buy	15,000	$19.69	$295K
2026-05-11	DUGGAN ROBERT W	director, 10%+ owner	Buy	660,233	$19.69	$13.00M
2026-03-23	UECKER DARRIN	director, officer	Award	100,000	—	—
2026-02-18	Danahy Kevin Patrick	officer	Option exercise	5,000	$1.53	$8K
2026-02-18	Danahy Kevin Patrick	officer	Sale	5,000	$23.64	$118K
2026-02-17	Danahy Kevin Patrick	officer	Option exercise	20,000	$1.53	$31K
2026-02-17	Danahy Kevin Patrick	officer	Sale	20,000	$23.63	$473K
2026-02-13	Danahy Kevin Patrick	officer	Option exercise	20,000	$1.53	$31K
2026-02-13	Danahy Kevin Patrick	officer	Sale	20,000	$23.53	$471K
2026-02-12	Danahy Kevin Patrick	officer	Option exercise	20,000	$1.53	$31K
2026-02-12	Danahy Kevin Patrick	officer	Sale	20,000	$23.37	$467K
2026-02-11	Danahy Kevin Patrick	officer	Option exercise	20,000	$1.53	$31K
2026-02-11	Danahy Kevin Patrick	officer	Sale	20,000	$25.20	$504K
2026-02-10	Danahy Kevin Patrick	officer	Option exercise	20,000	$1.53	$31K
2026-02-10	Danahy Kevin Patrick	officer	Sale	20,000	$23.52	$470K
2026-02-09	Danahy Kevin Patrick	officer	Option exercise	20,000	$1.53	$31K
2026-02-09	Danahy Kevin Patrick	officer	Sale	20,000	$21.45	$429K
2026-02-05	Sainz Maria	director	Award	3,104	$13.69	$42K
2026-01-08	Sainz Maria	director	Award	50,000	$14.72	$736K
2025-10-02	Danahy Kevin Patrick	officer	Option exercise	4,600	$1.53	$7K
2025-10-02	Danahy Kevin Patrick	officer	Sale	4,600	$18.53	$85K
2025-09-19	Danahy Kevin Patrick	officer	Option exercise	400	$1.53	$612
2025-09-19	Danahy Kevin Patrick	officer	Sale	400	$18.48	$7K

Showing 25 of 46

Other 13D/G Filings on PULSE BIOSCIENCES, INC.

Filed	Form	Filer	Stake	Shares
2026-05-13	SCHEDULE 13D/A	DUGGAN ROBERT W	—	49,706,423	view →
2021-07-02	SC	DUGGAN ROBERT W	—	—	view →
2021-05-11	SC	DUGGAN ROBERT W	—	—	view →
2018-02-26	SC	MARLETT CHRISTOPHER A	—	—	view →

Other Filings by DUGGAN ROBERT W

Filed	Form	Issuer	Stake	Shares
2026-05-13	SCHEDULE 13D/A	Pulse Biosciences, Inc. PLSE	—	49,706,423	view →
2022-08-18	SC	Summit Therapeutics Inc. SMMT	—	—	view →
2021-07-02	SC	Pulse Biosciences, Inc. PLSE	—	—	view →
2021-05-14	SC	Summit Therapeutics Inc. SMMT	—	—	view →
2021-05-11	SC	Pulse Biosciences, Inc. PLSE	—	—	view →
2021-04-22	SC	Summit Therapeutics Inc. SMMT	—	—	view →
2021-03-26	SC	Summit Therapeutics Inc. SMMT	—	—	view →
2020-11-10	SC	Summit Therapeutics Inc. SMMT	—	—	view →
2020-10-07	SC	Summit Therapeutics Inc. SMMT	—	—	view →
2020-01-16	SC	Summit Therapeutics plc SMMT	—	—	view →
2019-12-27	SC	Summit Therapeutics plc SMMT	—	—	view →
2019-04-05	SC	Achaogen, Inc.	—	—	view →
2019-03-20	SC	Achaogen, Inc.	—	—	view →
2019-01-18	SC	Aurinia Pharmaceuticals Inc. AUPH	—	—	view →
2018-05-07	SC	Achaogen Inc	—	—	view →
2018-04-24	SC	Achaogen Inc	—	—	view →
2018-03-14	SC	Achaogen Inc	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →